FiLeClo is a biotech startup focused on developing a platform of small molecules with versatile applications. The most advanced is an oncology program with one of the drug candidates on the verge of Phase I, but there are also programs dedicated to the following indications: -antimicrobial, -antiviral, -antiprotozoal, -anti-obesity.